abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

31 Oct 2001

Author:
Patti Waldmeir, Financial Times

Of patents and panics: US intellectual property law finely balances competing interests. Hasty wartime amendments would be risky, says Patti Waldmeir

...Bayer, the Cipro patent-holder, was condemned for using its patent to keep generic anti-anthrax drugs out of the hands of soon-to-be-sick Americans. The US secretary of health hinted he might abrogate the company's patent rights - and then used that threat to negotiate a sharp price cut.